Greeting from Chancellor Olaf Scholz at the BioNTech event on building production capacities on February 16, 2022, as a video message:

Germany Olaf Scholz · Member of the Bundestag

22 February 2022 · BioNTech event on building production capacities

Context
Scholz delivered a video message at a BioNTech event on February 16, 2022, marking the launch of new vaccine production facilities in Africa.
Main themes
Global COVID-19 vaccination, BioNTech mRNA vaccine production, Africa vaccine manufacturing capacity, EU-Africa partnership, G7 presidency health priorities, Covax initiative, pandemic preparedness, Project Lightspeed, equitable vaccine distribution, German government funding for vaccines
Duration
~5 min
16th percentile
Words
598
16th percentile
Sentences
40
25th percentile
Readability
45
49th percentile
Grade
10.6
28th percentile
Syntax
2.64
9th percentile
Vocabulary
2.46
94th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 30%30%
  • Economic 28%28%
  • Ceremonial 25%25%
  • Technological 10%10%
  • Geopolitical 8%8%
  • Environmental 0%0%
  • Institutional 0%0%
  • Not in focus 0%

40 sentences in 16 paragraphs

Dear President von der Leyen,

dear President Sall,

Excellencies,

dear Secretary-General Tedros,

dear Dr. Türeci,

dear Professor Sahin,

ladies and gentlemen,

about this time two years ago, the first Covid-19 infections were reported in Europe. At that time, we began to suspect that something of unknown magnitude could be coming our way.

A quickly available and effective vaccine seemed far off – almost like science fiction – after all, the fastest development of a new vaccine had previously taken at least five years. But that did not stop Özlem Türeci and Uğur Şahin. They suspected that the outbreak of this new virus could potentially escalate into an unprecedented pandemic. And they were determined to stop it. That was the birth of Project Lightspeed. The rest is history of science – and proof of what can be achieved through collaboration.

Right at the beginning of the pandemic, the German government quickly supported BioNTech and other companies with a tailored funding program. Today we know: Every euro was well-invested money! With the rapid expansion and conversion of the former Behringwerke in Marburg, BioNTech has created one of the largest mRNA production facilities in the world. This has set a model for establishing additional production facilities all over the world. They are urgently needed. Because every new variant is proof that we can only defeat this virus if we work together globally.

Recent studies show that people in Germany are well aware of this and support funding for global vaccination campaigns. However, so far, just over half of the world's population is fully vaccinated. And vaccines are still distributed extremely unevenly worldwide.

A central focus of the German G7 presidency will therefore be the global fight against Covid-19 and the promotion of investments to prevent future pandemics. We are not only the second-largest donor to the Covax initiative, but we have also already provided over 100 million vaccine doses from our national stockpiles to more than 30 countries worldwide – especially to developing countries. We will continue this commitment in 2022.

At the same time, we are expanding global vaccine production. Together with South Africa, we have presented concrete recommendations as co-chairs of the G20 working group on vaccine manufacturing. And as part of the "Team Europe" initiative, we have so far raised 500 million euros for the establishment of vaccine production in Africa. Because it is neither ethically justifiable nor sustainable that only one percent of the vaccines distributed in Africa are also produced there.

Today we are taking a big step to change that: As the European and African Union, we are working hand in hand to kickstart local vaccine production in Ghana, Senegal, South Africa, and Rwanda. Once completed, the production facilities there will not only contribute to overcoming the current pandemic. They will also open up long-term economic opportunities and play a positive role in the fight against other deadly diseases such as tuberculosis and malaria.

For me, this is an excellent example of what a new partnership between the African Union and the European Union should be based on: respect, innovation, sustainability, and opportunities. These are the building blocks of the shared vision for our two continents that we want to adopt at tomorrow's summit between the European Union and the African Union. And for those wondering how we intend to turn these words into action: Come to Marburg! Or very soon to Ghana, Senegal, South Africa, or Rwanda.

Thank you very much for your contribution to this joint effort! And I look forward to seeing at least some of you in person in Brussels tomorrow.